“Effects of the use of semaglutide as a pharmacological option for weight loss in adults with BMI > 25 Kg/m²: a scoping review”, RSD, vol. 12, no. 4, p. e9012440955, Apr. 2023, doi: 10.33448/rsd-v12i4.40955.